Review
doi: 10.1016/s0165-6147(00)01505-4.Restenosis: a challenge for pharmacology
Affiliations
- PMID:10871896
- DOI: 10.1016/s0165-6147(00)01505-4
Item in Clipboard
Review
Restenosis: a challenge for pharmacology
H Bult. Trends Pharmacol Sci.2000 Jul.
Display options
Format
Display options
Format
Abstract
The quest for an anti-restenotic drug continues to be a major challenge in the field of cardiovascular pharmacology because most therapies with proven efficacy in experimental neointima models have failed to limit restenosis. Some drug classes, including glycoprotein IIb/IIIa antagonists, nitric oxide donors and the antioxidant probucol, have recently demonstrated potential benefits in clinical trials. Progress in the development of local delivery systems for administration of drugs, antisense oligonucleotides or genes, in combination with an improved understanding of the pathogenesis of restenosis holds promise for ultimate pharmacotherapy of this condition.
Similar articles
- Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation.Ishiwata S, Verheye S, Robinson KA, Salame MY, de Leon H, King SB 3rd, Chronos NA.Ishiwata S, et al.J Am Coll Cardiol. 2000 Apr;35(5):1331-7. doi: 10.1016/s0735-1097(00)00528-3.J Am Coll Cardiol. 2000.PMID:10758977
- Restenosis after coronary angioplasty.Hamon M, Bauters C, McFadden EP, Wernert N, Lablanche JM, Dupuis B, Bertrand ME.Hamon M, et al.Eur Heart J. 1995 Aug;16 Suppl I:33-48. doi: 10.1093/eurheartj/16.suppl_i.33.Eur Heart J. 1995.PMID:8829956Review.
- Eplerenone suppresses neointima after coronary stenting in pigs: could it be extrapolated to stent restenosis in humans?Celik T, Iyisoy A, Kursaklioglu H, Isik E.Celik T, et al.Int J Cardiol. 2007 Jan 31;115(1):97-8; author reply 99-100. doi: 10.1016/j.ijcard.2005.12.025. Epub 2006 Jun 22.Int J Cardiol. 2007.PMID:16797750No abstract available.
- Defining coronary restenosis. Newer clinical and angiographic paradigms.Kuntz RE, Baim DS.Kuntz RE, et al.Circulation. 1993 Sep;88(3):1310-23. doi: 10.1161/01.cir.88.3.1310.Circulation. 1993.PMID:8353892Review.No abstract available.
- Neointimal response following rotational atherectomy compared to balloon angioplasty in a porcine model of coronary in-stent restenosis.McKenna CJ, Wilson SH, Camrud AR, Berger PB, Holmes DR Jr, Schwartz RS.McKenna CJ, et al.Cathet Cardiovasc Diagn. 1998 Nov;45(3):332-6. doi: 10.1002/(sici)1097-0304(199811)45:3<332::aid-ccd27>3.0.co;2-r.Cathet Cardiovasc Diagn. 1998.PMID:9829900
Cited by
- Polarity assessment of thermoresponsive poly(NIPAM-co-NtBA) copolymer films using fluorescence methods.Szczupak B, Ryder AG, Togashi DM, Klymchenko AS, Rochev YA, Gorelov A, Glynn TJ.Szczupak B, et al.J Fluoresc. 2010 May;20(3):719-31. doi: 10.1007/s10895-010-0613-5. Epub 2010 Feb 24.J Fluoresc. 2010.PMID:20179998
- Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, Stocker R.Wu BJ, et al.J Exp Med. 2006 Apr 17;203(4):1117-27. doi: 10.1084/jem.20052321. Epub 2006 Apr 10.J Exp Med. 2006.PMID:16606673Free PMC article.
- Effects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid artery.Bruijns RH, Bult H.Bruijns RH, et al.Br J Pharmacol. 2001 Oct;134(3):473-83. doi: 10.1038/sj.bjp.0704281.Br J Pharmacol. 2001.PMID:11588101Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources